Sleep Apnea Devices Market Size, Share, Trends, Industry Analysis Report: By Devices (Diagnostic Devices and Therapeutic Devices), End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025

The global sleep apnea devices market size is expected treach USD 9.57 billion by 2034, according ta new study by Polaris Market Research. The report “Sleep Apnea Devices Market Size, Share, Trends, Industry Analysis Report: By Devices (Diagnostic Devices and Therapeutic Devices), End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.

Sleep apnea is a condition that occurs when the brain and body receive an inadequate amount of oxygen due tbreathing interruptions during sleep. Obstructive sleep apnea (OSA) is the most common type of sleep apnea, which is primarily triggered by blockage in the airway. Other forms of sleep apnea include central sleep apnea and complex sleep apnea syndrome. Sleep apnea is extensively observed in the elderly population. There are multiple instances where sleep apnea is left undiagnosed due tfactors such as non-specific exhibition of the disorder and lack of awareness amongst the patients. Tmanage or treat the condition, diagnostic tests are essential tidentify the most appropriate treatment devices for the patient.

The rising prevalence of sleep apnea, combined with accurate diagnosis and efficient treatment, a growing geriatric population, and rising awareness among individuals are among the key factors driving the sleep apnea devices market growth. Further, the rising adoption of technological advancements that improve patient safety and comfort is expected tdrive the sleep apnea devices market expansion, especially in major economies such as North America, during the forecast period.

The growing number of individuals worldwide suffering from sleep apnea is one of the major trends expected tboost the sleep apnea devices market demand during the forecast period. Also, the rising utilization of telemedicine, artificial intelligence, and mobile health in sleep products is anticipated tprovide lucrative growth opportunities for market participants in the coming years.

Sleep Apnea Devices Market Report Highlights

Based on devices, the therapeutic devices segment led the sleep apnea devices market with an 82.0% revenue share in 2024. The robust growth of the segment is attributed tthe crucial role of sleep apnea devices in treating and preventing sleep apnea by enhancing sleep quality, reducing snoring, and boosting overall mood.

Based on end users, the home care settings segment held the largest market share of 62% in 2024. This rising preference for homecare, fueled by its improved convenience and comfort, drives the growth of the segment.

North America dominated the market with a share of 50.2% in 2024, owing tfactors such as changing lifestyles, the growing prevalence of respiratory diseases, and the implementation of favorable government initiatives.

The Asia Pacific sleep apnea devices market is projected tregister the highest CAGR of 6.8% from 2025 t2034. The rising prevalence of sleep apnea is driving the demand for sleep apnea devices in the region.

Curative Medical, Inc.; ResMed; React Health (Respiratory Product Line from Invacare Corporation); Somnetics International, Inc.; Respironics (a subsidiary of Koninklijke Philips N.V.); Fisher & Paykel Healthcare Limited; Natus Medical Incorporated; Itamar Medical Ltd.; Nihon Kohden Corporation; SOMNOmedics GmbH; Compumedics; and BMC Medical Co., Ltd. are a few key players in the sleep apnea devices market.

Polaris Market Research has segmented the sleep apnea devices market report on the basis of devices, end users, and region:

By Devices Outlook (Revenue – USD Billion, 2020–2034)

Diagnostics Devices

Polysomnography Devices (PSG)

Respiratory Polygraphs

Pulse Oximeters

Actigraphy Devices

Therapeutics Devices

Positive Airway Pressure (PAP) Devices

Oxygen Devices

Oral Appliances

Adaptive ServVentilation (ASV) Devices

By End Users Outlook (Revenue – USD Billion, 2020–2034)

Hospitals & Sleep Laboratories

Home Care Settings

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America